Does total lesion prostate‐specific membrane antigen (PSMA) activity on <sup>68</sup>Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
PSMA<sub>TL</sub> correlates with PSA, PSA density, ISUP GG, RP histopathological findings and BCR. As an adjunct to SUV<sub>max</sub>, PSMA<sub>TL</sub> has the potential to be a useful prognostic tool. Further research is needed to assess its clinical utility.
Authors
- David Nadebaum (ORCID: https://orcid.org/0000-0002-9424-0659)
- Mohammadmehdi Adhami (ORCID: https://orcid.org/0000-0002-8326-6175)
- Jeremy Cheng
- Tho D. Pham (ORCID: https://orcid.org/0000-0002-5900-0289)
- Eldho Paul (ORCID: https://orcid.org/0000-0003-1263-7255)
- Martin Cherk (ORCID: https://orcid.org/0000-0003-3961-8679)
- Jeremy Grummet (ORCID: https://orcid.org/0000-0003-4382-8169)
- Ashley Baring
Institutions
- Alfred Health (AU)
- Monash University (AU)
Publication Details
- Journal
- BJUI Compass
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1002/bco2.70015
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AstraZeneca
- Monash University